Development of a respirable, sustained r
โ
Cory J. Hitzman; William F. Elmquist; Timothy S. Wiedmann
๐
Article
๐
2006
๐
John Wiley and Sons
๐
English
โ 245 KB
๐ 1 views
The release rate of 5-fluorouracil (5-FU) from lipid-coated nanoparticles (LNPs) was determined to develop a respirable delivery system for use as adjuvant (postsurgery) therapy for lung cancer. LNPs were prepared by spray drying, and the in vitro release was measured by microdialysis. The compositi